𝔖 Bobbio Scriptorium
✦   LIBER   ✦

WAF1 expression andp53mutations in human colorectal cancers

✍ Scribed by Aijin Wang; Naoki Yoshimi; Natsuko Ino; Takuji Tanaka; Hideki Mori


Book ID
105140206
Publisher
Springer-Verlag
Year
1997
Tongue
English
Weight
628 KB
Volume
123
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


p21WAF1/CIP1 expression in colorectal ca
✍ Viale, Giuseppe; Pellegrini, Caterina; Mazzarol, Giovanni; Maisonneuve, Patrick; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 3 views

Defects in the mechanisms controlling the cell cycle are crucial in cell transformation and/or tumour progression. p21 WAF1/CIP1 is an inhibitor of cyclin-dependent kinases, induced by p53-dependent and p53-independent pathways, which can block progression through the cell cycle. p21 WAF1/CIP1 expre

Molecular epidemiology of human cancer r
✍ Bennett, William P.; Hussain, S. Perwez; Vahakangas, Kirsi H.; Khan, Mohammed A. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 2 views

The p53 tumour suppressor gene is at the crossroads of a network of cellular pathways including cell cycle checkpoints, DNA repair, chromosomal segregation, and apoptosis. These pathways have evolved to maintain the stability of the genome during cellular stress from DNA damage, hypoxia, and activat

Reduced p21WAF1/CIP1 expression and p53
✍ A M Hui; Y Kanai; M Sakamoto; H Tsuda; S Hirohashi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 352 KB

RNase H 0 reverse transcriptase (GIBCO-BRL, Gaithersburg, MD). ase chain reaction; SSCP, single-strand conformation polymorphism; mRNA, messenger p21 WAF1/CIP1 messenger RNA (mRNA) was amplified with the follow-RNA; cdk, cyclin dependent kinase.

p21/WAF1, p53 and PCNA expression and p5
✍ Lan Fang Qin; Irene O. L. Ng; Sheung T. Fan; Matthew Ng πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 443 KB πŸ‘ 2 views

The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs